Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
OMER
OMER
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OMER News
Omeros Corporation Under Investigation for Securities Law Violations
4h ago
Globenewswire
Omeros Corporation Faces Securities Fraud Investigation
6d ago
PRnewswire
High Options Trading Volume for Qualcomm and Replimune
Jun 26 2026
NASDAQ.COM
Omeros Shares Drop 25% After EU Panel Rejects Narsoplimab Therapy
Jun 26 2026
seekingalpha
Omeros' Yartemlea Therapy Faces EU Rejection
Jun 26 2026
stocktwits
Omeros Provides Update on Narsoplimab Review by EMA
Jun 26 2026
Newsfilter
Investment Comparison Between NovoCure and Omeros
Jun 22 2026
Fool
Investment Choices in Gene Editing and Rare Disease Treatments
Jun 20 2026
NASDAQ.COM
Choosing Between Gene Editing and Orphan Disease Treatments
Jun 20 2026
Fool
Omeros Corporation to Host 2026 Annual Shareholders Meeting
Jun 15 2026
Newsfilter
Omeros and SEI Investments Show High Options Trading Volume
Jun 12 2026
NASDAQ.COM
Omeros Reports Strong Q1 2026 Earnings with Positive Cash Flow
May 14 2026
seekingalpha
Omeros Reports Q1 Revenue Growth Following Drug Launch
May 14 2026
stocktwits
Omeros Q1 Earnings Exceed Expectations
May 13 2026
seekingalpha
Sagimet Biosciences Appoints New Chief Medical Officer
Apr 20 2026
NASDAQ.COM
Omeros Corp's Yartemlea Receives J-Code Support
Apr 17 2026
stocktwits
Show More News
